Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer AT Shaw, DW Kim, R Mehra, DSW Tan, E Felip, LQM Chow, DR Camidge, ... New England Journal of Medicine 370 (13), 1189-1197, 2014 | 1837 | 2014 |
Safety and efficacy of durvalumab (MEDI4736), an anti–programmed cell death ligand-1 immune checkpoint inhibitor, in patients with advanced urothelial bladder cancer C Massard, MS Gordon, S Sharma, S Rafii, ZA Wainberg, J Luke, ... Journal of Clinical Oncology 34 (26), 3119, 2016 | 898 | 2016 |
NCCN guidelines insights: colon cancer, version 2.2018 AB Benson, AP Venook, MM Al-Hawary, L Cederquist, YJ Chen, ... Journal of the National Comprehensive Cancer Network 16 (4), 359-369, 2018 | 893 | 2018 |
Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology AB Benson, AP Venook, MM Al-Hawary, L Cederquist, YJ Chen, ... Journal of the National Comprehensive Cancer Network 16 (7), 874-901, 2018 | 877 | 2018 |
Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology AB Benson, AP Venook, L Cederquist, E Chan, YJ Chen, HS Cooper, ... Journal of the National Comprehensive Cancer Network 15 (3), 370-398, 2017 | 765 | 2017 |
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial DW Kim, R Mehra, DSW Tan, E Felip, LQM Chow, DR Camidge, ... The lancet oncology 17 (4), 452-463, 2016 | 507 | 2016 |
Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry S Sharma, S Fulton International journal of obesity 37 (3), 382-389, 2013 | 453 | 2013 |
International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module VD Rosenthal, HM Al-Abdely, AA El-Kholy, SAA AlKhawaja, ... American journal of infection control 44 (12), 1495-1504, 2016 | 423 | 2016 |
International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module VD Rosenthal, DG Maki, Y Mehta, H Leblebicioglu, ZA Memish, ... American journal of infection control 42 (9), 942-956, 2014 | 409 | 2014 |
A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies F Giles, T Fischer, J Cortes, G Garcia-Manero, J Beck, F Ravandi, ... Clinical Cancer Research 12 (15), 4628-4635, 2006 | 378 | 2006 |
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells W Fiskus, S Sharma, B Shah, BP Portier, SGT Devaraj, K Liu, SP Iyer, ... Leukemia 28 (11), 2155-2164, 2014 | 296 | 2014 |
Targeting Axl and Mer kinases in cancer A Verma, SL Warner, H Vankayalapati, DJ Bearss, S Sharma Molecular cancer therapeutics 10 (10), 1763-1773, 2011 | 263 | 2011 |
Adaptations in brain reward circuitry underlie palatable food cravings and anxiety induced by high-fat diet withdrawal S Sharma, MF Fernandes, S Fulton International journal of obesity 37 (9), 1183-1191, 2013 | 254 | 2013 |
Colon cancer, version 3.2014 AB Benson, AP Venook, T Bekaii-Saab, E Chan, YJ Chen, HS Cooper, ... Journal of the National Comprehensive Cancer Network 12 (7), 1028-1059, 2014 | 246 | 2014 |
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1–3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations SK Pal, JE Rosenberg, JH Hoffman-Censits, R Berger, DI Quinn, ... Cancer discovery 8 (7), 812-821, 2018 | 244 | 2018 |
A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF-Mutant Colorectal Cancer RMJM Van Geel, J Tabernero, E Elez, JC Bendell, A Spreafico, M Schuler, ... Cancer discovery 7 (6), 610-619, 2017 | 238 | 2017 |
Rectal cancer, version 2.2015 AB Benson, AP Venook, T Bekaii-Saab, E Chan, YJ Chen, HS Cooper, ... Journal of the National Comprehensive Cancer Network 13 (6), 719-728, 2015 | 233 | 2015 |
Rectal cancer AB Benson, T Bekaii-Saab, E Chan, YJ Chen, MA Choti, HS Cooper, ... Journal of the National Comprehensive Cancer Network 10 (12), 1528-1564, 2012 | 214 | 2012 |
High-Throughput Virtual Screening Identifies Novel N′-(1-Phenylethylidene)-benzohydrazides as Potent, Specific, and Reversible LSD1 Inhibitors V Sorna, ER Theisen, B Stephens, SL Warner, DJ Bearss, ... Journal of medicinal chemistry 56 (23), 9496-9508, 2013 | 208 | 2013 |
LSD1 activates a lethal prostate cancer gene network independently of its demethylase function A Sehrawat, L Gao, Y Wang, A Bankhead III, SK McWeeney, CJ King, ... Proceedings of the National Academy of Sciences 115 (18), E4179-E4188, 2018 | 205 | 2018 |